Reardon, David A.
Desjardins, Annick
Rixe, Olivier
Cloughesy, Timothy
Alekar, Shilpa
Williams, Jason H.
Li, Ray
Taylor, Carrie Turich
Lassman, Andrew B.
Funding for this research was provided by:
Pfizer
Article History
Received: 7 April 2020
Accepted: 10 May 2020
First Online: 20 May 2020
Compliance with ethical standards
:
: DA Reardon declares research support (paid to DFCI): Acerta Phamaceuticals, Agenus, Celldex, EMD Serono, Incyte, Inovio, Midatech, Omniox, and Tragara; Advisory/consultation (paid to Dr Reardon): AbbVie, Advantagene, Agenus, Amgen, Bayer, Bristol-Myers Squibb, Celldex, DelMar, EMD Serono, Genentech/Roche, Inovio, Merck, Merck KGaA, Monteris, Novocure, Oncorus, Oxigene, Regeneron, Stemline, and Taiho Oncology Inc; Honoraria (paid to Dr Reardon): AbbVie, Advantagene, Agenus, Bristol-Myers Squibb, Celldex, EMD Serono, Genentech/Roche, Inovio, Merck, Merck KGaA, Monteris, Novocure, Oncorus, Oxigene, Regeneron, Stemline, and Taiho Oncology Inc; A Desjardins declares research research support (paid to Duke): Orbus Therapeutics, Genentech/Roche, Triphase Accelerator, Symphogen A/S; has served as consultant/participated in advisory boards (paid to Dr Desjardins: Orbus Therapeutics and Istari Oncology; as stock options in Istari Oncology; and patent on the use of the oncolytic poliovirus for the treatment of solid tumors; T Cloughesy declares research support from AstraZeneca, honoraria from Roche for serving on the Speakers Bureau, has served as a consultant/participated in advisory boards for VBL, Bayer, GW Pharma, Tocagen, Del Mar, Amgen, QED, Merck, Karyopharm, Odonate, Pascal Biosciences, Agios, is a Board member for Global Coalition for Adaptive Research 501 ©3, has stock options with Notable Labs, has a provisional patent application for compositions and methods for treating cancer; O Rixe declares research support from: Kyowa/Kirin, Oxford Biotherapeutics, Nanobiotix, IMV Inc, Newlink, Seattle Genetics, has served on the advisory committee for Kyowa/Kirin, Bexion, and is a stock shareholder in Bexion; S Alekar is an employee of Pfizer and hold stock in Pfizer, JH Williams is an employee of Pfizer and hold stock in Pfizer, CT Taylor is an employee of Pfizer and hold stock in Pfizer, R Li is an employee of Pfizer and hold stock in Pfizer; AB Lassman declares grants and non-financial support from Pfizer, during the conduct of the study; personal fees and non-financial support from Bioclinica as an expert blinded independent reviewer of clinical and imaging data for a BMS-sponsored trial, grants, personal fees and non-financial support from Karyopharm, personal fees from Sapience, personal fees from Magnolia Innovation, personal fees and non-financial support from Guidepoint Global, personal fees and non-financial support from Abbott Molecular, grants, personal fees and non-financial support from QED Therapeutics, personal fees from GLG, personal fees from Olson Research Group, personal fees from Biostrategies Group, personal fees and non-financial support from Forma, personal fees from Clarion Health Care Consulting, grants, personal fees and non-financial support from Bayer, personal fees from Defined Health, personal fees from Research America, personal fees from Advanced Focus, personal fees from Expert Connect, personal fees from Elsevier, grants, personal fees and non-financial support from Orbus, personal fees and non-financial support from Northwest Biotherapeutics, grants, personal fees and non-financial support from AbbVie, personal fees from Bionest Partners, personal fees from Antheneum, personal fees from DecioBio, personal fees from Connected Research and Consulting, personal fees from Health Advisors Bureau/Medefield, grants, personal fees and non-financial support from Agios, personal fees from RICCA Group, personal fees from Medsurvey, personal fees from Focus Forward Incentives, personal fees from WebMD, personal fees from Celgene, personal fees from prIME Oncology, personal fees from marketplusresearch.com, personal fees from Market Strategies International, personal fees from MSI Survey, personal fees from Cortice Biosciences, grants, personal fees and non-financial support from Kadmon, personal fees from Schlesinger Associates, personal fees and non-financial support from Novocure, personal fees and non-financial support from Physicians' Education Resource/Chemotherapy Foundation Symposium, grants and non-financial support from Genentech/Roche, grants and non-financial support from Amgen, grants and non-financial support from Millienium, grants and non-financial support from Celldex, grants and non-financial support from Novartis, non-financial support from Keryx as legacy to Aeterna Zentaris, grants and non-financial support from VBI Vaccines, grants and non-financial support from Beigene, grants and non-financial support from Oncoceutics, non-financial support from Tocagen, outside the submitted work.
: <i>Research involving human participants</i>: The study was approved by the institutional review board or independent ethics committee of each participating center and followed the Declaration of Helsinki and International Council for Harmonization Good Clinical Practice guidelines.
: All subjects or legally authorized representatives provided written informed consent.